Presentation TCT 2025 TCT 1228: Impact of Downsizing on Evolut Transcatheter Valve Leaflet Positioning During Valve-in-Valve: A Bench Study Presenter: Colin Jamieson October 27, 2025
Presentation TCT 2025 TCT 1222: Bioprosthetic Valve Fracture During VIV TAVR with a Self-Expanding Evolut Valve: Safety and Hemodynamics Outcomes from the Transcatheter Valve Therapy Registry Presenter: Keith B. Allen October 26, 2025
Presentation TCT 2025 TCT 1305: Evolut FX+ Implantation With a Protruding Left Main Coronary Stent Presenter: Stephane Noble October 26, 2025
Presentation TCT 2025 Retrograde Techniques for CTO PCI: An Evolution in Balancing Risk and Reward Presenter: Stephane Rinfret October 26, 2025
Presentation TCT 2025 A New FDA for a New Era: Innovation Demands Evolution! Presenter: Michael R. Jaff October 25, 2025
Presentation TCT 2025 TCT 1317: Preventing Sinus Sequestration in a Failed Evolut With ShortCut: A Dedicated Leaflet Modification Device Presenter: Bassem M. Chehab October 25, 2025
Presentation TCT 2025 TCT 869: Comparison of Evolut FX With Latest-Generation Evolut FX+ Transcatheter Aortic Valve Systems in Real-World Practice Presenter: Guilherme Attizzani October 25, 2025
Presentation TCT 2025 TCT 726: Coronary Obstruction Following Transcatheter Aortic Valve Replacement Using CoreValve or Evolut in Native Aortic Stenosis: A Systematic Review Presenter: Aoi Omori October 25, 2025
Presentation TCT 2025 TCT 2: Win Ratio Analysis of 1-Year Outcomes in the LANDMARK Trial: Myval vs Contemporary THVs (Sapien or Evolut) in Patients with Symptomatic Severe Aortic Stenosis Presenter: Akihiro Tobe October 25, 2025
News Conference News TCT 2024 Pooled All-Female Analysis Support Benefits of TAVI Over SAVR L.A. McKeown November 01, 2024
News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
Presentation TCT 2024 The Evolution of LAAO: Innovation Trends in Technology and Imaging Presenter: Thomas Waggoner October 30, 2024
Presentation TCT 2024 TCT 833: Fluoroscopic Evaluation of Post Evolut FX Implantation Commissural Alignment With Coronary Artery Ostium Presenter: Yair Feld October 30, 2024
Presentation TCT 2024 The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based) Presenter: Alexandre Abizaid October 29, 2024
Presentation TCT 2024 TCT 130: Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: LANDMARK Trial Presenter: Pieter Smits October 29, 2024
Presentation TCT 2024 TCT 337: Evolution of Untreated Moderate Mitral Regurgitation After Transcatheter Aortic Valve Implantation Presenter: Massimo Baudo October 28, 2024
Presentation TCT 2024 TCT 933: Win Ratio Analysis of LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis Presenter: Patrick Serruys October 28, 2024
Presentation TCT 2024 TCT 1009: Effect of Statin on Different Stages of Coronary Plaque Evolution Defined by Topological Data Analysis of Coronary Atherosclerosis Presenter: Hyun Jin Ahn October 28, 2024
Presentation TCT 2024 TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry Presenter: Anthony Matta October 28, 2024